NantKwest, Inc. | Note Agreements | Business Contracts

Promissory Note between the Company and Nant Capital, LLC dated December 12, 2022 (Filed With SEC on December 12, 2022)

Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantWorks, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantCancerStemCell, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantMobile, LLC dated August 31, 2022 (Filed With SEC on November 9, 2022)

Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021 (Filed With SEC on December 20, 2021)

Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC (Filed With SEC on March 10, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC (Filed With SEC on January 19, 2021)

Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC (Filed With SEC on January 19, 2021)

Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC (Filed With SEC on January 19, 2021)

NantKwest, Inc. (72) | Note Agreements (16)